Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning
First publishedAug 19, 10:49 UTC
Last updatedAug 20, 13:37 UTC · 11m ago
24 outlets over time — hover a bar for its window & outletslast updated











Answer
A new jab extended the length of time patients were cancer free, but it is unclear for how long.
Reported by 24 outlets — BBC US & Canada, NYT Home, NPR Health, CBS News, NBC News, and 11 more. See all sources ↓
Read the full report at BBC US & Canada ↗
Why it matters
24 outlets are covering this world story — one to watch as reporting develops.
In brief
- What's the story?
- A new jab extended the length of time patients were cancer free, but it is unclear for how long.
- How widely is it covered?
- 24 outlets, average source rating 7.2/10.
- When was it last updated?
- 11m ago.
Different angles across outlets
Coverage map
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card16 outlets1CoverageScouting report
Moderna’s and Merck’s personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks soaring
Sources16TypeCoverageBBC US & Canada
NYT Home
NPR Health
CBS News
NBC News
Al Jazeera
Axios
MarketWatch
Ars Technica
The Hill
TIME
CNBC Top News
Fortune
Seattle Times
Investing.com · Stock Market
New York Post
Related in the knowledge graph
Sources (24)
Avg source rating 7.2/10BBC US & Canada9
NYT Home9
NPR Health8
CBS News8
CBS News8
CBS News8
NBC News8
NBC News8
CBS News8
NBC News8
Al Jazeera7
Axios7
MarketWatch7
Ars Technica7
The Hill7
TIME7
MarketWatch7
CNBC Top News7
Fortune6
Seattle Times6
Seattle Times6
Investing.com · Stock Market6
Investing.com · Stock Market6
New York Post5
Processing cluster
A1A2A3B1B2B3